Search details
1.
Using HCV-viremic organs for lung transplantation does not confer higher rejection rates compared to HCV-negative organs.
Clin Transplant
; 38(2): e15260, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38369851
2.
Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients.
Transpl Infect Dis
; 26(1): e14209, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38059638
3.
Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients.
Clin Transplant
; 32(8): e13300, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29806967
4.
A Pilot Trial for Prevention of Hepatitis C Virus Transmission From Donor to Organ Transplant Recipient With Short-Course Glecaprevir/Pibrentasvir.
Open Forum Infect Dis
; 9(11): ofac550, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36420058
Results
1 -
4
de 4
1
Next >
>>